Evotec AG Stock - Target price: 28 €

Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Show me how to use this page

Evotec AG Stock

Evotec AG gained 1.880% today.
The stock is one of the favorites of our community with 31 Buy predictions and 2 Sell predictions.
As a result the target price of €28.00 shows a positive potential of 22.861% compared to the current price of €22.79 for Evotec AG.

What does Evotec do?

Pros and Cons of Evotec AG in the next few years

Pros

1

EBIT growth >5% per year expected

1

Revenue growth >5% per year expected

Cons

0

-

Opinions by others

Comments

Buy Evotec AG

0

Buy Evotec AG

0

Published

Prediction Buy

Perf. (%)

Target price

Change

Buy beendet

0

You may not comment on this article as you either did not confirm your account yet or were blocked. If you think this is a mistake please contact us. Show more

Other discussions about Evotec AG Stock

Trading Evotec AG

Trading Evotec AG

NightTrain

New thread Forum

News

DGAP-News: EVOTEC AND BIOASTER PARTNER TO BUILD A TECHNOLOGY AND INNOVATION HUB IN LYON: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC AND BIOASTER PARTNER TO BUILD A TECHNOLOGY AND INNOVATION HUB IN LYON

DGAP-News: EVOTEC AND BIOASTER PARTNER TO BUILD A TECHNOLOGY AND INNOVATION HUB IN LYON

0

DGAP-News: EVOTEC EXPANDS ITS PROPRIETARY PATIENT DATABASE INTO LIVER DISEASE WITH UNIQUE ACCESS TO QUOD BIOBANK: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC EXPANDS ITS PROPRIETARY PATIENT DATABASE INTO LIVER DISEASE WITH UNIQUE ACCESS TO QUOD BIOBANK

DGAP-News: EVOTEC EXPANDS ITS PROPRIETARY PATIENT DATABASE INTO LIVER DISEASE WITH UNIQUE ACCESS TO QUOD BIOBANK

0

DGAP-News: EVOTEC AND CENTOGENE EXPAND COLLABORATION INTO GAUCHER DISEASE: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC AND CENTOGENE EXPAND COLLABORATION INTO GAUCHER DISEASE

DGAP-News: EVOTEC AND CENTOGENE EXPAND COLLABORATION INTO GAUCHER DISEASE

0

DGAP-News: EVOTEC AND NOVO NORDISK FORM STRATEGIC ALLIANCE TO DEVELOP NOVEL THERAPIES FOR KIDNEY DISEASES: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC AND NOVO NORDISK FORM STRATEGIC ALLIANCE TO DEVELOP NOVEL THERAPIES FOR KIDNEY DISEASES

DGAP-News: EVOTEC AND NOVO NORDISK FORM STRATEGIC ALLIANCE TO DEVELOP NOVEL THERAPIES FOR KIDNEY DISEASES

0

DGAP-News: EVOTEC SE REPORTS FIRST HALF-YEAR 2020 RESULTS AND CORPORATE UPDATES: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC SE REPORTS FIRST HALF-YEAR 2020 RESULTS AND CORPORATE UPDATES

DGAP-News: EVOTEC SE REPORTS FIRST HALF-YEAR 2020 RESULTS AND CORPORATE UPDATES

0

DGAP-News: EVOTEC RECEIVES CARB-X FUNDING FOR RESOLUTE'S ANTIBIOTIC PROJECT: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC RECEIVES CARB-X FUNDING FOR RESOLUTE'S ANTIBIOTIC PROJECT

DGAP-News: EVOTEC RECEIVES CARB-X FUNDING FOR RESOLUTE'S ANTIBIOTIC PROJECT

0

DGAP-News: EVOTEC SE TO REPORT FIRST HALF-YEAR 2020 RESULTS ON 12 AUGUST 2020: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC SE TO REPORT FIRST HALF-YEAR 2020 RESULTS ON 12 AUGUST 2020

DGAP-News: EVOTEC SE TO REPORT FIRST HALF-YEAR 2020 RESULTS ON 12 AUGUST 2020

0

DGAP-News: EVOTEC AND SECARNA PHARMACEUTICALS FORM STRATEGIC PARTNERSHIP IN THE FIELD OF ANTISENSE THERAPY: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC AND SECARNA PHARMACEUTICALS FORM STRATEGIC PARTNERSHIP IN THE FIELD OF ANTISENSE THERAPY

DGAP-News: EVOTEC AND SECARNA PHARMACEUTICALS FORM STRATEGIC PARTNERSHIP IN THE FIELD OF ANTISENSE THERAPY

0

DGAP-News: JUST - EVOTEC BIOLOGICS TO PRODUCE MONOCLONAL ANTIBODY PRODUCTS AGAINST COVID-19 FOR THE DEPARTMENT OF DEFENSE: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: JUST - EVOTEC BIOLOGICS TO PRODUCE MONOCLONAL ANTIBODY PRODUCTS AGAINST COVID-19 FOR THE DEPARTMENT OF DEFENSE

DGAP-News: JUST - EVOTEC BIOLOGICS TO PRODUCE MONOCLONAL ANTIBODY PRODUCTS AGAINST COVID-19 FOR THE DEPARTMENT OF DEFENSE

0

DGAP-News: EVOTEC ENTERS PARTNERSHIP WITH QUANTRO THERAPEUTICS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC ENTERS PARTNERSHIP WITH QUANTRO THERAPEUTICS

DGAP-News: EVOTEC ENTERS PARTNERSHIP WITH QUANTRO THERAPEUTICS

0

DGAP-News: EVOTEC INITIATES 'CAMPUS CURIE' IN TOULOUSE : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC INITIATES 'CAMPUS CURIE' IN TOULOUSE

DGAP-News: EVOTEC INITIATES 'CAMPUS CURIE' IN TOULOUSE

0

DGAP-News: EVOTEC, SAMSARA BIOCAPITAL, AND KCK LAUNCH AUTOBAHN LABS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC, SAMSARA BIOCAPITAL, AND KCK LAUNCH AUTOBAHN LABS

DGAP-News: EVOTEC, SAMSARA BIOCAPITAL, AND KCK LAUNCH AUTOBAHN LABS

0

DGAP-News: EVOTEC SE VIRTUAL ANNUAL GENERAL MEETING 2020 APPROVES ALL PROPOSED AGENDA ITEMS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC SE VIRTUAL ANNUAL GENERAL MEETING 2020 APPROVES ALL PROPOSED AGENDA ITEMS

DGAP-News: EVOTEC SE VIRTUAL ANNUAL GENERAL MEETING 2020 APPROVES ALL PROPOSED AGENDA ITEMS

0

DGAP-News: JUST - EVOTEC BIOLOGICS PARTNERS WITH ABL ON DEVELOPMENT OF BROADLY NEUTRALISING ANTIBODY AGAINST HIV: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: JUST - EVOTEC BIOLOGICS PARTNERS WITH ABL ON DEVELOPMENT OF BROADLY NEUTRALISING ANTIBODY AGAINST HIV

DGAP-News: JUST - EVOTEC BIOLOGICS PARTNERS WITH ABL ON DEVELOPMENT OF BROADLY NEUTRALISING ANTIBODY AGAINST HIV

0

DGAP-News: EVOTEC: CYPROTEX AWARDED NEW 5 YEAR AGREEMENT WITH THE US ENVIRONMENTAL PROTECTION AGENCY ('EPA'): http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC: CYPROTEX AWARDED NEW 5 YEAR AGREEMENT WITH THE US ENVIRONMENTAL PROTECTION AGENCY ('EPA')

DGAP-News: EVOTEC: CYPROTEX AWARDED NEW 5 YEAR AGREEMENT WITH THE US ENVIRONMENTAL PROTECTION AGENCY ('EPA')

0

DGAP-News: EVOTEC PARTICIPATES IN EXSCIENTIA'S FINANCING ROUND: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC PARTICIPATES IN EXSCIENTIA'S FINANCING ROUND

DGAP-News: EVOTEC PARTICIPATES IN EXSCIENTIA'S FINANCING ROUND

0

DGAP-News: EVOTEC SE REPORTS FIRST QUARTER 2020 RESULTS AND PROVIDES CORPORATE UPDATE: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC SE REPORTS FIRST QUARTER 2020 RESULTS AND PROVIDES CORPORATE UPDATE

DGAP-News: EVOTEC SE REPORTS FIRST QUARTER 2020 RESULTS AND PROVIDES CORPORATE UPDATE

0

DGAP-News: EVOTEC SE TO REPORT FIRST QUARTER 2020 RESULTS ON 14 MAY 2020: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC SE TO REPORT FIRST QUARTER 2020 RESULTS ON 14 MAY 2020

DGAP-News: EVOTEC SE TO REPORT FIRST QUARTER 2020 RESULTS ON 14 MAY 2020

0

DGAP-News: JUST - EVOTEC BIOLOGICS TO COLLABORATE WITH OLOGY BIOSERVICES ON ANTIBODIES AGAINST CORONAVIRUS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: JUST - EVOTEC BIOLOGICS TO COLLABORATE WITH OLOGY BIOSERVICES ON ANTIBODIES AGAINST CORONAVIRUS

DGAP-News: JUST - EVOTEC BIOLOGICS TO COLLABORATE WITH OLOGY BIOSERVICES ON ANTIBODIES AGAINST CORONAVIRUS

0

DGAP-News: EVOTEC REGAINS GLOBAL RIGHTS TO BETA CELL REPLACEMENT THERAPY: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC REGAINS GLOBAL RIGHTS TO BETA CELL REPLACEMENT THERAPY

DGAP-News: EVOTEC REGAINS GLOBAL RIGHTS TO BETA CELL REPLACEMENT THERAPY

0

DGAP-News: EVOTEC ENTERS NANOMEDICINE THROUGH STRATEGIC PARTNERSHIP WITH LEON-NANODRUGS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC ENTERS NANOMEDICINE THROUGH STRATEGIC PARTNERSHIP WITH LEON-NANODRUGS

DGAP-News: EVOTEC ENTERS NANOMEDICINE THROUGH STRATEGIC PARTNERSHIP WITH LEON-NANODRUGS

0

DGAP-News: EVOTEC AND TAKEDA ENTER INTO MULTI-YEAR GENE THERAPY RESEARCH ALLIANCE: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC AND TAKEDA ENTER INTO MULTI-YEAR GENE THERAPY RESEARCH ALLIANCE

DGAP-News: EVOTEC AND TAKEDA ENTER INTO MULTI-YEAR GENE THERAPY RESEARCH ALLIANCE

0

DGAP-News: EVOTEC EXPANDS INTO GENE THERAPY: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC EXPANDS INTO GENE THERAPY

DGAP-News: EVOTEC EXPANDS INTO GENE THERAPY

0

DGAP-News: EVOTEC EXPANDS ITS IPSC-BASED CELL THERAPY PLATFORM EVOCELLS THROUGH LICENSING AGREEMENT WITH PANCELLA: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC EXPANDS ITS IPSC-BASED CELL THERAPY PLATFORM EVOCELLS THROUGH LICENSING AGREEMENT WITH PANCELLA

DGAP-News: EVOTEC EXPANDS ITS IPSC-BASED CELL THERAPY PLATFORM EVOCELLS THROUGH LICENSING AGREEMENT WITH PANCELLA

0

DGAP-News: EVOTEC AND ILDONG TO COLLABORATE WITH DEVELOPMENT PROJECTS ON INDIGO PLATFORM: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC AND ILDONG TO COLLABORATE WITH DEVELOPMENT PROJECTS ON INDIGO PLATFORM

DGAP-News: EVOTEC AND ILDONG TO COLLABORATE WITH DEVELOPMENT PROJECTS ON INDIGO PLATFORM

0